1114 related articles for article (PubMed ID: 18400254)
41. Primary gastric inflammatory myofibroblastic tumor: a clinicopathologic and immunohistochemical study of 5 cases.
Shi H; Wei L; Sun L; Guo A
Pathol Res Pract; 2010 May; 206(5):287-91. PubMed ID: 20304564
[TBL] [Abstract][Full Text] [Related]
42. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
43. Differential diagnosis of inflammatory myofibroblastic tumour and low-grade myofibroblastic sarcoma: two case reports with a literature review.
Ni C; Xu YY; Zhou SH; Wang SQ
J Int Med Res; 2011; 39(1):311-20. PubMed ID: 21672335
[TBL] [Abstract][Full Text] [Related]
44. Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis.
Mergan F; Jaubert F; Sauvat F; Hartmann O; Lortat-Jacob S; Révillon Y; Nihoul-Fékété C; Sarnacki S
J Pediatr Surg; 2005 Oct; 40(10):1581-6. PubMed ID: 16226988
[TBL] [Abstract][Full Text] [Related]
45. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
46. [Clinicopathologic study of sinonasal inflammatory myofibroblastic tumor].
He CY; Jin YL; Yang DM; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):166-71. PubMed ID: 20450762
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG
Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176
[TBL] [Abstract][Full Text] [Related]
48. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
[TBL] [Abstract][Full Text] [Related]
49. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.
Patel AS; Murphy KM; Hawkins AL; Cohen JS; Long PP; Perlman EJ; Griffin CA
Cancer Genet Cytogenet; 2007 Jul; 176(2):107-14. PubMed ID: 17656252
[TBL] [Abstract][Full Text] [Related]
50. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
Chen ST; Lee JC
Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
[TBL] [Abstract][Full Text] [Related]
51. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
[TBL] [Abstract][Full Text] [Related]
52. [Clinicopathologic features of extrapulmonary inflammatory myofibroblastic tumor].
Li H; Shen Q; Xia Q; Shi S; Zhang R; Yu B; Ma H; Lu Z; Wang X; He Y; Zhou X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):370-4. PubMed ID: 25208985
[TBL] [Abstract][Full Text] [Related]
53. Low-grade myofibroblastic sarcomas of the maxilla.
Qiu JY; Liu P; Shi C; Han B
Oncol Lett; 2015 Feb; 9(2):619-625. PubMed ID: 25624890
[TBL] [Abstract][Full Text] [Related]
54. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
Yu L; Liu J; Lao IW; Luo Z; Wang J
Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
[TBL] [Abstract][Full Text] [Related]
55. [Gastrointestinal inflammatory myofibroblastic tumor: a clinicopathologic study].
Wang QP; Gan MF; Zhang JW; Weng SX; Zhang LN
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):758-762. PubMed ID: 30317730
[No Abstract] [Full Text] [Related]
56. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
[TBL] [Abstract][Full Text] [Related]
57. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
58. Cutaneous inflammatory pseudotumor--a spectrum of various diseases?
El Shabrawi-Caelen L; Kerl K; Cerroni L; Soyer HP; Kerl H
J Cutan Pathol; 2004 Oct; 31(9):605-11. PubMed ID: 15330992
[TBL] [Abstract][Full Text] [Related]
59. Asymptomatic inflammatory myofibroblastic tumor of the heart: immunohistochemical profile, differential diagnosis, and review of the literature.
Pucci A; Valori A; Muscio M; Garofalo L; Ferroni F; Abbruzzese PA
Cardiovasc Pathol; 2009; 18(3):187-90. PubMed ID: 18436455
[TBL] [Abstract][Full Text] [Related]
60. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
